Lumos Diagnostics Holdings Limited (LDXHF)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 11.13 Million | 10.43 Million | 11.63 Million | 18.97 Million | 5.78 Million | 4.47 Million |
| Cost of Revenue | 4.56 Million | 14.71 Million | 7.17 Million | 18.33 Million | 3.27 Million | 2.44 Million |
| Gross Profit | 6.56 Million | -4.28 Million | 4.45 Million | 638.08 Thousand | 2.5 Million | 2.03 Million |
| Operating Expenses | 7.09 Million | 5.79 Million | 25.52 Million | 11.71 Million | 13.2 Million | 4.97 Million |
| Selling, General and Administrative Expenses | 10.73 Million | 4.73 Million | 19.13 Million | 10.46 Million | 11.29 Million | 4.4 Million |
| Research and Development Expenses | 69 Thousand | 416.83 Thousand | 1.32 Million | 1.24 Million | 1.9 Million | 573.49 Thousand |
| Other Expenses | - | -641.59 Thousand | 17 Thousand | - | - | - |
| Cost and Expenses | 16.13 Million | 20.5 Million | 32.7 Million | 30.04 Million | 16.47 Million | 7.42 Million |
| Operating Income | -7.12 Million | -10.07 Million | -21.49 Million | -11.07 Million | -10.69 Million | -2.94 Million |
| Interest Expense | 1.04 Million | 2.4 Million | 572 Thousand | 4.24 Million | 517.2 Thousand | 453.25 Thousand |
| Income Tax Expense | - | 2.00 | 189 Thousand | 4.00 | -59.32 Thousand | -610.96 Thousand |
| Earnings before Tax | -8.59 Million | -8.88 Million | -45.72 Million | -15.12 Million | -9.31 Million | -5.2 Million |
| Net Income | -8.59 Million | -8.88 Million | -45.72 Million | -15.12 Million | -9.25 Million | -4.59 Million |
| Earnings Per Share Basic | -0.02 | -0.04 | -0.30 | -0.09 | -0.05 | -0.03 |
| Earnings Per Share Diluted | -0.02 | -0.04 | -0.30 | -0.09 | -0.05 | -0.03 |
| Weighted Average Shares Outstanding | 493.63 Million | 234.84 Million | 152.32 Million | 172.4 Million | 172.4 Million | 161.76 Million |
| Weighted Average Shares Outstanding (Diluted) | 493.63 Million | 234.84 Million | 152.32 Million | 172.4 Million | 172.4 Million | 161.76 Million |
| Gross Margin | 0.59 | -0.41 | 0.38 | 0.03 | 0.43 | 0.45 |
| EBIT Margin | -0.49 | -0.62 | -1.61 | -0.56 | -1.75 | -0.55 |
| Profit Margin | -0.77 | -0.85 | -3.93 | -0.80 | -1.60 | -1.03 |
| EBITDA | -5.43 Million | -4.92 Million | -40.23 Million | -10.47 Million | -10.41 Million | -2.46 Million |
| Earnings Before Tax Margin | -0.64 | -0.97 | -1.85 | -0.58 | -1.85 | -0.66 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 11.32 Million | 4.18 Million | 4.18 Million | 2.88 Million | 1.38 Million | 10.43 Million |
| Cost of Revenue | 14.95 Million | 1.61 Million | 1.61 Million | 6.41 Million | 665.5 Thousand | 14.71 Million |
| Gross Profit | -3.63 Million | 2.56 Million | 2.56 Million | -3.52 Million | 717.5 Thousand | -4.28 Million |
| Operating Expenses | 4.15 Million | 2.91 Million | 2.91 Million | 2.34 Million | 3.52 Million | 5.79 Million |
| Selling, General and Administrative Expenses | - | 2.89 Million | 2.89 Million | 2.23 Million | 2.85 Million | - |
| Research and Development Expenses | - | 20.5 Thousand | 20.5 Thousand | 114.77 Thousand | 55 Thousand | - |
| Other Expenses | -544.23 Thousand | -541.86 Thousand | - | - | - | -641.59 Thousand |
| Cost and Expenses | 19.11 Million | 4.53 Million | 4.53 Million | 8.76 Million | 4.18 Million | 20.5 Million |
| Operating Income | -7.78 Million | -354 Thousand | -354 Thousand | -5.87 Million | -2.81 Million | -10.07 Million |
| Interest Expense | 1.04 Million | 318.03 Thousand | - | 836.79 Thousand | - | 2.4 Million |
| Income Tax Expense | 1.00 | 3.00 | -659.5 Thousand | - | - | 2.00 |
| Earnings before Tax | -8.74 Million | -1.08 Million | -1.08 Million | -6.69 Million | -3.2 Million | -8.88 Million |
| Net Income | -8.74 Million | -1.08 Million | -1.08 Million | -6.69 Million | -3.2 Million | -8.88 Million |
| Earnings Per Share Basic | - | -0.00 | -0.00 | -0.01 | -0.01 | - |
| Earnings Per Share Diluted | - | -0.00 | -0.00 | -0.01 | -0.01 | - |
| Weighted Average Shares Outstanding | 493.63 Million | 482.07 Million | 482.07 Million | 473.65 Million | 444.48 Million | 234.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 493.63 Million | 481.94 Million | 481.94 Million | 473.65 Million | 444.44 Million | 234.84 Million |
| Gross Margin | -0.32 | 0.61 | 0.61 | -1.22 | 0.52 | -0.41 |
| EBIT Margin | - | -0.20 | -0.17 | -1.58 | -1.58 | - |
| Profit Margin | -0.77 | -0.26 | -0.26 | -2.32 | -2.32 | -0.85 |
| EBITDA | - | -842.25 Thousand | -691.33 Thousand | -4.57 Million | -2.19 Million | - |
| Earnings Before Tax Margin | -0.69 | -0.08 | -0.08 | -2.04 | -2.04 | -0.97 |
HMAN
STS
ABSSF
1741
301137
KGBLY